These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37565105)

  • 1. A Retrospective Study to Evaluate the Perioperative Clinical Characteristics and Outcomes of Rhino-Orbital Cerebral Mucormycosis in COVID-19 Patients at a Tertiary Care Hospital in India.
    Kumari R; Talawar P; Tripaty DK; Singla D; Kaushal A; Sharma S; Malhotra M; Boruah P; Sangadala P; Kumar KS
    Cureus; 2023 Jul; 15(7):e41613. PubMed ID: 37565105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
    Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
    Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative anesthesia challenges and outcomes of patients with Rhino-Orbito-Cerebral Mucormycosis during the second wave of COVID-19 pandemic: An observational study.
    Kumari K; Rathod D; Meshram T; Mohammed S; Raju S; Sharma A; Chaudhary B; Bhatia P
    J Anaesthesiol Clin Pharmacol; 2023; 39(4):615-621. PubMed ID: 38269163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
    Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
    Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum ferritin is associated with severity of orbital disease in COVID-19-associated rhino-orbito-cerebral mucormycosis: A quantitative analysis.
    Tanwar S; Mishra N; Sharma P; Kaur A
    Indian J Ophthalmol; 2024 Jul; ():. PubMed ID: 38990622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhino Orbital Cerebral Mucormycosis in Covid-19 Crisis.
    Vadivel S; Gowrishankar M; Vetrivel K; Sujatha B; Navaneethan P
    Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):1014-1020. PubMed ID: 36855632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, predictors, and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care center in South India.
    Thanjavur Sethuraman K; Athimanjeri Thiruvengadam J; Ravichandran A; Thoppappatty Sengottaiyan S
    Curr Med Mycol; 2023 Sep; 9(3):33-37. PubMed ID: 38361963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.
    Reddy YM; Yeduguri S; Reddy N VS; Parida S; Kamatham SN; Pidaparthi L; Jaiswal SK; Sadhvani B; Tourani V; Kumar S; Challa S; Murthy JM
    J Mycol Med; 2022 May; 32(2):101252. PubMed ID: 35134736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaesthetic concerns in post-COVID mucormycosis at a tertiary care hospital in India: An observational study.
    Lahiri S; Kundu AK; Ray M
    Indian J Anaesth; 2023 May; 67(5):471-474. PubMed ID: 37333699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile, prognostic factors, and outcomes of rhino-orbital-cerebral mucormycosis in the setting of COVID-19: A retrospective study.
    Hanumappa SM; Karuppannasamy D
    Saudi J Ophthalmol; 2023; 37(2):100-106. PubMed ID: 37492213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
    Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
    Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated Rhino-Orbital Mucormycosis in a Tertiary Health Care Center in Odisha, India.
    Acharya S; Behera SK; Purohit S; Sahu A; Panda BB; Behera S
    Cureus; 2023 Aug; 15(8):e43811. PubMed ID: 37731437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.